Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Clinical trial NCT02093221 · TERMINATED
Trial details
- NCT number
- NCT02093221
- Sponsor
- Grifols Therapeutics LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2017-01-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.